As of 2025-11-01, the Intrinsic Value of Edgewise Therapeutics Inc (EWTX) is -7.15 USD. This EWTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 18.67 USD, the upside of Edgewise Therapeutics Inc is -138.31%.
Based on its market price of 18.67 USD and our intrinsic valuation, Edgewise Therapeutics Inc (EWTX) is overvalued by 138.31%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.15 - -7.15 | -7.15 | -138.31% |
| P/E | (27.18) - (29.41) | (28.47) | -252.5% |
| DDM - Stable | (15.16) - (64.84) | (40.00) | -314.2% |
| DDM - Multi | (0.22) - (0.70) | (0.33) | -101.8% |
| Market Cap (mil) | 1,966.88 |
| Beta | 2.01 |
| Outstanding shares (mil) | 105.35 |
| Enterprise Value (mil) | 1,923.48 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.30% |
| Cost of Debt | 5.00% |
| WACC | 6.09% |